Skip to main content
Earnings Labs
Gyre Therapeutics, Inc. logo

Gyre Therapeutics, Inc. (GYRE) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$7.04

+7.73%

Mkt Cap $654.23M

EPS — Estimate vs Actual

Quarterly History

Q1 2026

May 7, 2026

$31.61M$22.52M-28.75%-$0.06-$0.10-66.67%
Q1 2026

Mar 12, 2026

$35.43M$37.20M+4.97%$0.06$0.04-29.42%
Q4 2025

Nov 7, 2025

$36.30M$30.56M-15.81%$0.05$0.06+20.00%
Q3 2025

Aug 11, 2025

$34.30M$26.77M-21.95%$0.03$0.02-33.33%
Q2 2025

May 9, 2025

$28.70M$22.06M-23.14%$0.03$0.03+0.00%
Q1 2025

Mar 17, 2025

$23.50M$27.87M+18.60%$0.04$0.01-75.00%
Q4 2024

Nov 13, 2024

—$25.49M——$0.02—
Q3 2024

Aug 13, 2024

$113.45M$25.23M-77.77%—$0.01—
Q2 2024

May 9, 2024

—$27.17M——$0.04—
Q1 2024

Mar 26, 2024

—$29.98M—-$0.60-$0.68-13.57%
Q4 2023

Oct 26, 2023

—$30.74M—-$0.75-$1.05-40.00%
Q3 2023

Aug 14, 2023

—$26.14M—-$0.07-$0.07+0.00%
Q2 2023

May 15, 2023

—$24.44M—-$1.05$0.14+113.47%
Q1 2023

Mar 30, 2023

$400.00K$794.00K+98.50%-$1.57-$0.05+96.53%
Q4 2022

Nov 14, 2022

—$29.17M—-$1.50-$0.05+96.35%
Q3 2022

Aug 15, 2022

—$23.33M—-$3.67$0.08+102.06%
Q2 2022

May 9, 2022

—$794.00K——$0.08—
Q1 2022

Mar 31, 2022

$797.00K$2.44M+206.15%-$6.85-$0.65+90.55%
Q4 2021

Nov 12, 2021

—$2.30M——-$0.80—
Q3 2021

Aug 5, 2021

—$1.13M——-$0.64—
Q2 2021

May 6, 2021

—$1.47M——-$0.79—
Q1 2021

Mar 4, 2021

—$2.03M——-$0.85—
Q4 2020

Nov 5, 2020

—$893.00K——-$0.73—
Q3 2020

Aug 6, 2020

—$1.66M——-$0.96—
Q2 2020

May 11, 2020

—$16.37M——-$0.28—
Q1 2020

Feb 20, 2020

————-$1.13—
Q4 2019

Nov 7, 2019

————-$1.06—
Q3 2019

Aug 1, 2019

————-$1.15—
Q2 2019

May 2, 2019

————-$1.26—
Q1 2019

Mar 8, 2019

—$6.00K——-$0.91—
Q4 2018

Nov 1, 2018

————-$0.64—
Q3 2018

Aug 2, 2018

————-$0.54—
Q2 2018

May 3, 2018

—$6.00K——-$0.56—
Q1 2018

Mar 19, 2018

—$318.00K——-$1.26—
Q4 2017

Nov 2, 2017

—$318.00K——-$1.34—
Q3 2017

Aug 3, 2017

—$111.00K——-$1.52—
Q2 2017

May 11, 2017

—$271.00K——-$4.57—
Q1 2017

Mar 8, 2017

—$71.00K——-$4.68—
Q4 2016

Nov 3, 2016

—$109.00K——-$6.04—
Q3 2016

Aug 4, 2016

—$109.00K——-$6.33—
Q2 2016

May 5, 2016

—$109.00K——-$4.71—
Q1 2016

Mar 9, 2016

—$109.00K——-$6.73—
Q4 2015

Nov 5, 2015

—$109.00K——-$14.00—
Q3 2015

Jul 31, 2015

—$859.00K——-$13.44—
Q2 2015

May 7, 2015

—$60.00K——-$20.98—
Q1 2015

Mar 16, 2015

—$127.00K——-$14.38—
Q4 2014

Nov 6, 2014

—$25.00K——-$15.10—
Q3 2014

Aug 7, 2014

—$36.00K——-$25.28—
Q2 2014

May 8, 2014

—$87.00K——-$46.67—
Q1 2014

Mar 14, 2014

—$93.00K——-$41.68—
Q4 2013

Nov 6, 2013

————-$40.27—
Q3 2013

Aug 7, 2013

————-$38.63—
Q2 2013

May 8, 2013

—$3.54M——-$25.19—
Q1 2013

Mar 15, 2013

—$590.00K——-$49.58—
Q4 2012

Nov 8, 2012

—$768.00K——-$24.70—
Q3 2012

Aug 9, 2012

—$33.65M——$45.24—
Q2 2012

May 9, 2012

—$22.86M——$7.01—
Q1 2012

Mar 6, 2012

—$18.95M——-$30.82—
Q4 2011

Nov 3, 2011

—$18.95M——-$28.48—
Q3 2011

Aug 9, 2011

—$20.74M——-$7.71—
Q2 2011

May 9, 2011

—$38.99M——$43.48—
Q1 2011

Mar 11, 2011

—$23.50M——-$7.51—
Q4 2010

Nov 5, 2010

—$21.80M——$8.65—
Q3 2010

Aug 9, 2010

—$20.90M——$13.17—
Q2 2010

May 10, 2010

—$19.52M——$24.46—
Q1 2010

Mar 11, 2010

—$3.43M——-$100.88—
Q4 2009

Nov 6, 2009

—$12.66M——$5.20—
Q3 2009

Aug 7, 2009

—$2.83M——-$40.60—
Q2 2009

May 11, 2009

—$6.14M——-$19.67—
Q1 2009

Mar 13, 2009

—$6.52M——-$22.83—
Q4 2008

Nov 7, 2008

—$4.14M——-$32.19—
Q3 2008

Aug 7, 2008

—$5.16M——-$28.68—
Q2 2008

May 8, 2008

—$4.28M——-$25.47—
Q1 2008

Mar 14, 2008

—$3.56M——-$39.18—
Q4 2007

Nov 9, 2007

—$3.13M——-$38.51—
Q3 2007

Aug 8, 2007

—$2.84M——-$45.31—
Q2 2007

May 11, 2007

—$2.05M——-$26.30—
Q1 2007

Mar 22, 2007

—$25.34M——$92.03—
Q4 2006

Nov 13, 2006

—$998.29K——-$26.72—
Q3 2006

Aug 11, 2006

—$589.41K——-$31.08—
Q2 2006

May 26, 2006

—$606.12K——-$2012.33—
Q4 2005

Dec 31, 2005

—$238.73K——-$2588.45—
Q3 2005

Sep 30, 2005

—$338.31K——-$2763.66—
Q2 2005

Jun 30, 2005

—$299.65K——-$3260.46—
Q1 2005

Mar 31, 2005

—$303.23K——-$3013.68—